Mechanical Circulatory Support Devices – Medical Devices Pipeline Assessment, 2020

Mechanical Circulatory Support Devices are devices which replace or assist the pumping function of the ventricles. These devices support the functioning of a weak heart by pumping blood. GlobalData's Medical Devices sector report, “Mechanical Circulatory Support Devices – Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Mechanical Circulatory Support Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Mechanical Circulatory Support Devices Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Mechanical Circulatory Support Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Mechanical Circulatory Support Devices pipeline products.

Review of Recent Developments in the segment / industry

The Mechanical Circulatory Support Devices Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Mechanical Circulatory Support Devices- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Mechanical Circulatory Support Devices under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Mechanical Circulatory Support Devices and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Mechanical Circulatory Support Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Abbott Laboratories

Abiomed Inc

Arrow International Cr, A.S.

BioVentrix Inc

BiVacor Pty Ltd

Braile Biomedica Ltda

Calon Cardio-Technology Ltd

CardiacAssist Inc

CardiacBooster BV

CARDIAnove Inc

Carmat SAS

Carnegie Mellon University

Cleveland Clinic Hospital

Cleveland Clinic Lerner College of Medicine

Cleveland Heart Inc

CorAssist Cardiovascular Ltd

Corinnova Inc

CorWave

Drexel University

Duke University

Ension, Inc.

Evaheart Inc

Everheart Systems, LLC

FineHeart

Foster-Miller Inc (Inactive)

Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon

Georgia Institute of Technology

Grupo Vitalmex SA de CV

Harvard University

HeartWare International Inc

I M Sechenov Moscow State Medical University

Indian Institute of Technology Kharagpur

Indiana University

Inspired Therapeutics LLC

Jarvik Heart Inc

LaunchPoint Technologies Inc

Lausanne University Hospital

Leviticus Cardio Ltd

Levram Medical Systems Ltd

Lonestar Heart Inc

Mayo Clinic

Medtronic Plc

Michigan Critical Care Consultants Inc

MyoCardioCare, Inc.

Myotech, LLC (Inactive)

NeoCardial Technologies, LLC

Nipro Corp

Novapump GmbH

NuPulseCV

OregonHeart Inc (Inactive)

Pennsylvania State University

Perfusion Solution Inc

PlugMed Heart SAS

Procyrion Inc

Purdue University

Puzzle Medical Devices Inc

ReliantHeart, Inc.

RT Cardiac Systems Inc

Rutgers The State University of New Jersey

Scandinavian Real Heart AB

Sree Chitra Tirunal Institute for Medical Sciences & Technology

St. Jude Medical LLC

Sunshine Heart Company, Pty. Ltd.

Supira Medical Inc

Syncardia Systems LLC

TEDA International Cardiovascular Hospital

Terumo Corp

The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development

Thoratec LLC

Tokyo Medical and Dental University

U.S. Stem Cell Inc

University of Louisville

University of Tokyo

University of Virginia

Vadovations Inc

VASCOR Inc

Windmill Cardiovascular Systems, Inc.

W-Z BIOTECH, LLC

Yale University

Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 13

2 Introduction 15

2.1 Mechanical Circulatory Support Devices Overview 15

3 Products under Development 16

3.1 Mechanical Circulatory Support Devices – Pipeline Products by Stage of Development 16

3.2 Mechanical Circulatory Support Devices – Pipeline Products by Segment 17

3.3 Mechanical Circulatory Support Devices – Pipeline Products by Territory 18

3.4 Mechanical Circulatory Support Devices – Pipeline Products by Regulatory Path 19

3.5 Mechanical Circulatory Support Devices – Pipeline Products by Estimated Approval Date 20

3.6 Mechanical Circulatory Support Devices – Ongoing Clinical Trials 21

4 Mechanical Circulatory Support Devices – Pipeline Products under Development by Companies 22

4.1 Mechanical Circulatory Support Devices Companies – Pipeline Products by Stage of Development 22

4.2 Mechanical Circulatory Support Devices – Pipeline Products by Stage of Development 25

5 Mechanical Circulatory Support Devices Companies and Product Overview 29

5.1 Abbott Laboratories Company Overview 29

5.1.1 Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 29

5.2 Abiomed Inc Company Overview 30

5.2.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.3 Arrow International Cr, A.S. Company Overview 37

5.3.1 Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 37

5.4 BioVentrix Inc Company Overview 38

5.4.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.5 BiVacor Pty Ltd Company Overview 39

5.5.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.6 Braile Biomedica Ltda Company Overview 40

5.6.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 40

5.7 Calon Cardio-Technology Ltd Company Overview 41

5.7.1 Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.8 CardiacAssist Inc Company Overview 44

5.8.1 CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.9 CardiacBooster BV Company Overview 45

5.9.1 CardiacBooster BV Pipeline Products & Ongoing Clinical Trials Overview 45

5.10 CARDIAnove Inc Company Overview 46

5.10.1 CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.11 Carmat SAS Company Overview 47

5.11.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 47

5.12 Carnegie Mellon University Company Overview 51

5.12.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 51

5.13 Cleveland Clinic Hospital Company Overview 53

5.13.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 53

5.14 Cleveland Clinic Lerner College of Medicine Company Overview 54

5.14.1 Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 54

5.15 Cleveland Heart Inc Company Overview 56

5.15.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.16 CorAssist Cardiovascular Ltd Company Overview 58

5.16.1 CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.17 Corinnova Inc Company Overview 62

5.17.1 Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.18 CorWave Company Overview 67

5.18.1 CorWave Pipeline Products & Ongoing Clinical Trials Overview 67

5.19 Drexel University Company Overview 69

5.19.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 69

5.20 Duke University Company Overview 70

5.20.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 70

5.21 Ension, Inc. Company Overview 71

5.21.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

5.22 Evaheart Inc Company Overview 73

5.22.1 Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.23 Everheart Systems, LLC Company Overview 76

5.23.1 Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 76

5.24 FineHeart Company Overview 77

5.24.1 FineHeart Pipeline Products & Ongoing Clinical Trials Overview 77

5.25 Foster-Miller Inc (Inactive) Company Overview 78

5.25.1 Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78

5.26 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 79

5.26.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 79

5.27 Georgia Institute of Technology Company Overview 80

5.27.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 80

5.28 Grupo Vitalmex SA de CV Company Overview 81

5.28.1 Grupo Vitalmex SA de CV Pipeline Products & Ongoing Clinical Trials Overview 81

5.29 Harvard University Company Overview 82

5.29.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 82

5.30 HeartWare International Inc Company Overview 83

5.30.1 HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.31 I M Sechenov Moscow State Medical University Company Overview 93

5.31.1 I M Sechenov Moscow State Medical University Pipeline Products & Ongoing Clinical Trials Overview 93

5.32 Indian Institute of Technology Kharagpur Company Overview 94

5.32.1 Indian Institute of Technology Kharagpur Pipeline Products & Ongoing Clinical Trials Overview 94

5.33 Indiana University Company Overview 95

5.33.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview 95

5.34 Inspired Therapeutics LLC Company Overview 96

5.34.1 Inspired Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 96

5.35 Jarvik Heart Inc Company Overview 97

5.35.1 Jarvik Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 97

5.36 LaunchPoint Technologies Inc Company Overview 103

5.36.1 LaunchPoint Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.37 Lausanne University Hospital Company Overview 105

5.37.1 Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview 105

5.38 Leviticus Cardio Ltd Company Overview 106

5.38.1 Leviticus Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

5.39 Levram Medical Systems Ltd Company Overview 108

5.39.1 Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 108

5.40 Lonestar Heart Inc Company Overview 109

5.40.1 Lonestar Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.41 Mayo Clinic Company Overview 113

5.41.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 113

5.42 Medtronic Plc Company Overview 115

5.42.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 115

5.43 Michigan Critical Care Consultants Inc Company Overview 116

5.43.1 Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.44 MyoCardioCare, Inc. Company Overview 118

5.44.1 MyoCardioCare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118

5.45 Myotech, LLC (Inactive) Company Overview 120

5.45.1 Myotech, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 120

5.46 NeoCardial Technologies, LLC Company Overview 121

5.46.1 NeoCardial Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 121

5.47 Nipro Corp Company Overview 122

5.47.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 122

5.48 Novapump GmbH Company Overview 124

5.48.1 Novapump GmbH Pipeline Products & Ongoing Clinical Trials Overview 124

5.49 NuPulseCV Company Overview 126

5.49.1 NuPulseCV Pipeline Products & Ongoing Clinical Trials Overview 126

5.50 OregonHeart Inc (Inactive) Company Overview 130

5.50.1 OregonHeart Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 130

5.51 Pennsylvania State University Company Overview 131

5.51.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 131

5.52 Perfusion Solution Inc Company Overview 132

5.52.1 Perfusion Solution Inc Pipeline Products & Ongoing Clinical Trials Overview 132

5.53 PlugMed Heart SAS Company Overview 135

5.53.1 PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview 135

5.54 Procyrion Inc Company Overview 136

5.54.1 Procyrion Inc Pipeline Products & Ongoing Clinical Trials Overview 136

5.55 Purdue University Company Overview 139

5.55.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 139

5.56 Puzzle Medical Devices Inc Company Overview 140

5.56.1 Puzzle Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 140

5.57 ReliantHeart, Inc. Company Overview 141

5.57.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 141

5.58 RT Cardiac Systems Inc Company Overview 144

5.58.1 RT Cardiac Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 144

5.59 Rutgers The State University of New Jersey Company Overview 145

5.59.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 145

5.60 Scandinavian Real Heart AB Company Overview 147

5.60.1 Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview 147

5.61 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 148

5.61.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 148

5.62 St. Jude Medical LLC Company Overview 149

5.62.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 149

5.63 Sunshine Heart Company, Pty. Ltd. Company Overview 151

5.63.1 Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 151

5.64 Supira Medical Inc Company Overview 152

5.64.1 Supira Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 152

5.65 Syncardia Systems LLC Company Overview 153

5.65.1 Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview 153

5.66 TEDA International Cardiovascular Hospital Company Overview 159

5.66.1 TEDA International Cardiovascular Hospital Pipeline Products & Ongoing Clinical Trials Overview 159

5.67 Terumo Corp Company Overview 160

5.67.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 160

5.68 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Company Overview 162

5.68.1 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Pipeline Products & Ongoing Clinical Trials Overview 162

5.69 Thoratec LLC Company Overview 163

5.69.1 Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 163

5.70 Tokyo Medical and Dental University Company Overview 166

5.70.1 Tokyo Medical and Dental University Pipeline Products & Ongoing Clinical Trials Overview 166

5.71 U.S. Stem Cell Inc Company Overview 167

5.71.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 167

5.72 University of Louisville Company Overview 168

5.72.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 168

5.73 University of Tokyo Company Overview 169

5.73.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 169

5.74 University of Virginia Company Overview 170

5.74.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 170

5.75 Vadovations Inc Company Overview 171

5.75.1 Vadovations Inc Pipeline Products & Ongoing Clinical Trials Overview 171

5.76 VASCOR Inc Company Overview 172

5.76.1 VASCOR Inc Pipeline Products & Ongoing Clinical Trials Overview 172

5.77 Windmill Cardiovascular Systems, Inc. Company Overview 173

5.77.1 Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 173

5.78 W-Z BIOTECH, LLC Company Overview 175

5.78.1 W-Z BIOTECH, LLC Pipeline Products & Ongoing Clinical Trials Overview 175

5.79 Yale University Company Overview 176

5.79.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 176

6 Mechanical Circulatory Support Devices- Recent Developments 179

6.1 Jul 15, 2020: Researchers 3D print a working heart pump with real human cells 179

6.2 Mar 10, 2020: CARMAT announces that it has achieved record individual support of 2 years with its bioprosthesis 180

6.3 Mar 09, 2020: SynCardia Systems 50cc temporary Total Artificial Heart (TAH-t) now FDA approved 180

6.4 Mar 04, 2020: Study of 21,848 high-risk PCI patients demonstrates lower risk of death and complications in patients who receive PVADs (Impella) 181

6.5 Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019 182

6.6 Feb 20, 2020: Teleflex reports fourth quarter and full year 2019 results; provides 2020 guidance 183

6.7 Feb 17, 2020: CARMAT confirms the submission of a “forfait Innovation” dossier in France and its eligibility with observations received from the French National Authority for Health (HAS) 185

6.8 Feb 12, 2020: CARMAT reports its 2019 annual results and confirms its 2020 objectives 185

6.9 Feb 11, 2020: CorWave appoints Jim Schuermann as an Independent Director 188

6.10 Feb 06, 2020: Abiomed announces Q3 FY 2020 revenue of $222 million and

31.7% operating margin 189

6.11 Feb 05, 2020: Abbott's implantable heart pump system gets FDA approval 190

6.12 Feb 05, 2020: CARMAT announces FDA full approval to initiate US clinical feasibility study of its total Artificial Heart 190

6.13 Jan 23, 2020: Class 1 device recall HeartWare HVAD System battery charger AC adapter 191

6.14 Jan 21, 2020: Realheart releases footage from the animal trial surgeries 191

6.15 Jan 14, 2020: Novostia obtains EUR

2.5 million grant from the european union to support its heart valve technology 192

6.16 Jan 13, 2020: Abiomed announces preliminary Q3 FY 2020 revenue of $222 million, up 10% over prior year 192

6.17 Jan 08, 2020: Abbott receives FDA approval for heart pump implant procedure 193

6.18 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 194

6.19 Dec 17, 2019: Realheart on display at the Technical Museum 194

6.20 Dec 16, 2019: First patient enrolls in STEMI DTU randomized controlled FDA trial; study aims to further demonstrate Impella’s safety and effectiveness 195

6.21 Dec 16, 2019: First patient enrolls in STEMI DTU randomized controlled FDA trial; study aims to further demonstrate impella’s safety and effectiveness 196

6.22 Dec 09, 2019: CARMAT resumes enrollment in the PIVOTAL Study in the Czech Republic with its Artificial Heart implanted in a 12th patient 197

6.23 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 198

6.24 Dec 02, 2019: CARMAT granted authorization to resume the PIVOTAL study in Kazakhstan 199

6.25 Nov 27, 2019: CARMAT appoints Alexandre Eleonore as director of manufacturing 200

6.26 Nov 19, 2019: Impella heart pumps associated with complications after stent procedure 200

6.27 Nov 19, 2019: Abiomed Medical Office completes review of Observational Analysis of Impella Presented at AHA 201

6.28 Nov 19, 2019: CARMAT granted authorization to resume the PIVOTAL study in the Czech Republic 204

6.29 Nov 19, 2019: Improving the odds for patients with heart pumps 205

6.30 Nov 14, 2019: Clinical review demonstrates cost-effectiveness of Impella in high-risk PCI and Cardiogenic Shock 205

6.31 Nov 13, 2019: Micron Solutions reports 2019 third quarter results 208

6.32 Nov 06, 2019: CARMAT: the feedback after 6 years and 8 months of cumulative support shows a constant improvement in the clinical outcomes of patients in the PIVOTAL study 208

6.33 Nov 05, 2019: FDA labels recall of Abbott CentriMag System as Class I 209

6.34 Oct 31, 2019: First U.S. patients treated with Impella

5.5 with SmartAssist, a minimally invasive, forward flow heart pump 210

6.35 Oct 31, 2019: Teleflex reports third quarter 2019 results 210

6.36 Oct 31, 2019: Abiomed announces Q2 FY 2020 revenue of $205 million and

29.4% operating margin 212

6.37 Oct 30, 2019: FDA grants breakthrough status to Medtronic heart device 214

6.38 Oct 28, 2019: Hackensack University Medical Center first in U.S. to perform cardiovascular procedures using pioneering Impella

5.5 heart pump device 214

6.39 Oct 26, 2019: FDA post approval study demonstrates timely identification of Right Heart Failure and early use of Impella RP leads to higher survival 216

6.40 Oct 07, 2019: Abiomed announces 1,000th patient treated with impella in Japan 217

6.41 Sep 27, 2019: Study demonstrates early use of Impella can increase survival in cardiogenic shock; Escalation protocols initiated 219

6.42 Sep 26, 2019: Abiomed gets pre-market approval for Impella

5.5 in US 220

6.43 Sep 26, 2019: PROTECT III presented at TCT 2019 – Clinical data demonstrates protected PCI with Impella is associated with improved outcomes 221

7 Appendix 224

7.1 Methodology 224

7.2 About GlobalData 228

7.3 Contact Us 228

7.4 Disclaimer 228

List of Tables

Table 1: Mechanical Circulatory Support Devices – Pipeline Products by Stage of Development 16

Table 2: Mechanical Circulatory Support Devices – Pipeline Products by Segment 17

Table 3: Mechanical Circulatory Support Devices – Pipeline Products by Territory 18

Table 4: Mechanical Circulatory Support Devices – Pipeline Products by Regulatory Path 19

Table 5: Mechanical Circulatory Support Devices – Pipeline Products by Estimated Approval Date 20

Table 6: Mechanical Circulatory Support Devices – Ongoing Clinical Trials 21

Table 7: Mechanical Circulatory Support Devices Companies – Pipeline Products by Stage of Development 22

Table 8: Mechanical Circulatory Support Devices – Pipeline Products by Stage of Development 25

Table 9: Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 29

Table 10: Fully Implantable Left Ventricular Assist System – Product Status 29

Table 11: Fully Implantable Left Ventricular Assist System – Product Description 29

Table 12: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 13: AbioCor II – Product Status 30

Table 14: AbioCor II – Product Description 31

Table 15: Impella 5.5 With SmartAssist – Product Status 31

Table 16: Impella 5.5 With SmartAssist – Product Description 31

Table 17: Impella BTR – Product Status 32

Table 18: Impella BTR – Product Description 32

Table 19: Impella ECP – Product Status 32

Table 20: Impella ECP – Product Description 33

Table 21: Next Generation Impella CP – STEMI – Product Status 33

Table 22: Next Generation Impella CP – STEMI – Product Description 33

Table 23: Abiomed Inc – Ongoing Clinical Trials Overview 34

Table 24: Impella ECP – Use of the Impella ECP in Patients Undergoing an Elective High-risk Percutaneous Coronary Intervention: An Early Feasibility Study 35

Table 25: Next Generation Impella CP – STEMI – Primary Unloading and Delayed Reperfusion in St-elevation Myocardial Infarction: The STEMI-DTU Trial 36

Table 26: Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 27: CorAide Left Ventricular Assist System – Product Status 37

Table 28: CorAide Left Ventricular Assist System – Product Description 37

Table 29: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 30: PliCath HF – Product Status 38

Table 31: PliCath HF – Product Description 38

Table 32: BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Table 33: BiVACOR Device – Product Status 39

Table 34: BiVACOR Device – Product Description 39

Table 35: Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 40

Table 36: Blood Pump – Product Status 40

Table 37: Blood Pump – Product Description 40

Table 38: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Table 39: Calon MiniVAD – Product Status 41

Table 40: Calon MiniVAD – Product Description 41

Table 41: CathVAD – Product Status 42

Table 42: CathVAD – Product Description 42

Table 43: MicroVAD – Product Status 42

Table 44: MicroVAD – Product Description 43

Table 45: CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 46: Pediatric pVAD – Product Status 44

Table 47: Pediatric pVAD – Product Description 44

Table 48: CardiacBooster BV Pipeline Products & Ongoing Clinical Trials Overview 45

Table 49: Percutaneous Ventricular Assist Device – Product Status 45

Table 50: Percutaneous Ventricular Assist Device – Product Description 45

Table 51: CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Table 52: CARDIAnove Pump – Product Status 46

Table 53: CARDIAnove Pump – Product Description 46

Table 54: Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 47

Table 55: Artificial Heart – Product Status 47

Table 56: Artificial Heart – Product Description 48

Table 57: Carmat SAS – Ongoing Clinical Trials Overview 49

Table 58: Artificial Heart – Carmat Total Artificial Heart Early Feasibility Study 50

Table 59: Artificial Heart – Clinical Evaluation of the Carmat Total Artificial Heart for Patients with Advanced Heart Failure 50

Table 60: Artificial Heart – Multicentric Prospective Cohort Study in Patients with Irreversible Biventricular Heart Failure to Assess the Efficacy and Safety of Carmat TAH, Its Clinical Utility and Cost, as a Bridge to Transplantation 50

Table 61: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 51

Table 62: Non-Blood Contacting Muscle Powered VAD – Product Status 51

Table 63: Non-Blood Contacting Muscle Powered VAD – Product Description 51

Table 64: tVAD – Heart Failure – Product Status 52

Table 65: tVAD – Heart Failure – Product Description 52

Table 66: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 53

Table 67: PediPump – Product Status 53

Table 68: PediPump – Product Description 53

Table 69: Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 54

Table 70: Continuous-Flow Total Artificial Heart – Product Status 54

Table 71: Continuous-Flow Total Artificial Heart – Product Description 54

Table 72: Pediatric Continuous-Flow Total Artificial Heart – Product Status 55

Table 73: Pediatric Continuous-Flow Total Artificial Heart – Product Description 55

Table 74: Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Table 75: SmartHeart LVAD – Product Status 56

Table 76: SmartHeart LVAD – Product Description 56

Table 77: SmartHeart TAH – Product Status 57

Table 78: SmartHeart TAH – Product Description 57

Table 79: CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

Table 80: CORolla – Product Status 58

Table 81: CORolla – Product Description 58

Table 82: ImCardia – Product Status 59

Table 83: ImCardia – Product Description 59

Table 84: CorAssist Cardiovascular Ltd – Ongoing Clinical Trials Overview 60

Table 85: CORolla – CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility 61

Table 86: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 62

Table 87: CardiacSTAR – Bridge To Decision – Product Status 62

Table 88: CardiacSTAR – Bridge To Decision – Product Description 62

Table 89: CardiacSTAR – Bridge To Recovery – Product Status 63

Table 90: CardiacSTAR – Bridge To Recovery – Product Description 63

Table 91: CardiacSTAR – Bridge To Transplant – Product Status 63

Table 92: CardiacSTAR – Bridge To Transplant – Product Description 64

Table 93: CardiacSTAR – Destination Therapy – Product Status 64

Table 94: CardiacSTAR – Destination Therapy – Product Description 64

Table 95: CardiacSTAR – Heart Rehabilitation – Product Status 65

Table 96: CardiacSTAR – Heart Rehabilitation – Product Description 65

Table 97: EpicHeart – Soft Robotic Heart Device – Product Status 65

Table 98: EpicHeart – Soft Robotic Heart Device – Product Description 66

Table 99: CorWave Pipeline Products & Ongoing Clinical Trials Overview 67

Table 100: CorWave Nemo – Product Status 67

Table 101: CorWave Nemo – Product Description 67

Table 102: CorWave Neptune – Product Status 68

Table 103: CorWave Neptune – Product Description 68

Table 104: Drexel University Pipeline Products & Ongoing Clinical Trials Overview 69

Table 105: Intravascular Blood Pump – Product Status 69

Table 106: Intravascular Blood Pump – Product Description 69

Table 107: Duke University Pipeline Products & Ongoing Clinical Trials Overview 70

Table 108: Para-Aortic Blood Pump – Product Status 70

Table 109: Para-Aortic Blood Pump – Product Description 70

Table 110: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

Table 111: CardioFlowPQ – Product Status 71

Table 112: CardioFlowPQ – Product Description 71

Table 113: Magnetic Levitation Motor – Product Status 72

Table 114: Magnetic Levitation Motor – Product Description 72

Table 115: Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Table 116: EVAHEART Left Ventricular Assist System – Product Status 73

Table 117: EVAHEART Left Ventricular Assist System – Product Description 73

Table 118: Evaheart Inc – Ongoing Clinical Trials Overview 74

Table 119: EVAHEART Left Ventricular Assist System – Prospective Multi-Center Randomized Study for Evaluating the EVAHEART2 Left Ventricular Assist System: the COMPETENCE Trial 75

Table 120: Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 76

Table 121: Fully Implantable Left Ventricular Assist Device – Product Status 76

Table 122: Fully Implantable Left Ventricular Assist Device – Product Description 76

Table 123: FineHeart Pipeline Products & Ongoing Clinical Trials Overview 77

Table 124: ICOMS – Product Status 77

Table 125: ICOMS – Product Description 77

Table 126: Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78

Table 127: MagScrew Total Artificial Heart – Product Status 78

Table 128: MagScrew Total Artificial Heart – Product Description 78

Table 129: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 79

Table 130: Ventricular Assist Device – Product Status 79

Table 131: Ventricular Assist Device – Product Description 79

Table 132: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 80

Table 133: OptiFlo – Product Status 80

Table 134: OptiFlo – Product Description 80

Table 135: Grupo Vitalmex SA de CV Pipeline Products & Ongoing Clinical Trials Overview 81

Table 136: Vitacor – UVAD – Product Status 81

Table 137: Vitacor – UVAD – Product Description 81

Table 138: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 82

Table 139: Soft Robotic Sleeve – Product Status 82

Table 140: Soft Robotic Sleeve – Product Description 82

Table 141: HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Table 142: BiVAD – Product Status 83

Table 143: BiVAD – Product Description 84

Table 144: HeartWare IV-VAD – Product Status 84

Table 145: HeartWare IV-VAD – Product Description 84

Table 146: HVAD System – Destination Therapy – Product Status 85

Table 147: HVAD System – Destination Therapy – Product Description 85

Table 148: Levacor Rotary VAD – Product Status 86

Table 149: Levacor Rotary VAD – Product Description 86

Table 150: Longhorn – Product Status 86

Table 151: Longhorn – Product Description 87

Table 152: MiFlow VAD – Product Status 87

Table 153: MiFlow VAD – Product Description 87

Table 154: Miniaturized Ventricular Assist Device (MVAD) Pump – Product Status 88

Table 155: Miniaturized Ventricular Assist Device (MVAD) Pump – Product Description 88

Table 156: VCAN Trans-Mitral – Product Status 88

Table 157: VCAN Trans-Mitral – Product Description 89

Table 158: HeartWare International Inc – Ongoing Clinical Trials Overview 90

Table 159: Miniaturized Ventricular Assist Device (MVAD) Pump – Multi Center, Prospective, Non-randomized, Single-arm Trial Evaluating the Clinical Safety and Performance of the HeartWare MVAD System for the Treatment of Advanced Heart Failure 91

Table 160: HVAD System – Destination Therapy – Apogee International 92

Table 161: I M Sechenov Moscow State Medical University Pipeline Products & Ongoing Clinical Trials Overview 93

Table 162: Cardiac Assist Device – Children – Product Status 93

Table 163: Cardiac Assist Device – Children – Product Description 93

Table 164: Indian Institute of Technology Kharagpur Pipeline Products & Ongoing Clinical Trials Overview 94

Table 165: Artificial Heart – Product Status 94

Table 166: Artificial Heart – Product Description 94

Table 167: Indiana University Pipeline Products & Ongoing Clinical Trials Overview 95

Table 168: Bi-Conical Heart Pump – Product Status 95

Table 169: Bi-Conical Heart Pump – Product Description 95

Table 170: Inspired Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 96

Table 171: INSPIRE System – Product Status 96

Table 172: INSPIRE System – Product Description 96

Table 173: Jarvik Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 97

Table 174: Jarvik 2000 Heart – Bridge To Transplant – Product Status 97

Table 175: Jarvik 2000 Heart – Bridge To Transplant – Product Description 98

Table 176: Jarvik 2000 Heart – Destination Therapy – Product Status 98

Table 177: Jarvik 2000 Heart – Destination Therapy – Product Description 98

Table 178: Jarvik 2015 – Product Status 99

Table 179: Jarvik 2015 – Product Description 99

Table 180: Jarvik Heart Inc – Ongoing Clinical Trials Overview 100

Table 181: Jarvik 2000 Heart – Destination Therapy – Evaluation of the Jarvik 2000 Left Ventricular Assist System with Post-auricular Connector–destination Therapy Study 101

Table 182: Jarvik 2015 – Pumps for Kids, Infants, and Neonates 102

Table 183: LaunchPoint Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 103

Table 184: Pediaflow Pediatric VAD – Product Status 103

Table 185: Pediaflow Pediatric VAD – Product Description 103

Table 186: Streamliner VAD – Product Status 104

Table 187: Streamliner VAD – Product Description 104

Table 188: Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview 105

Table 189: RollingHeart – Product Status 105

Table 190: RollingHeart – Product Description 105

Table 191: Leviticus Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

Table 192: FiVAD System – Product Status 106

Table 193: FiVAD System – Product Description 107

Table 194: Hybrid FILVAS – Product Status 107

Table 195: Hybrid FILVAS – Product Description 107

Table 196: Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 108

Table 197: LEVRAM-Ventricular Assist Device – Product Status 108

Table 198: LEVRAM-Ventricular Assist Device – Product Description 108

Table 199: Lonestar Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 109

Table 200: Algisyl-LVR Surgical Device – Product Status 109

Table 201: Algisyl-LVR Surgical Device – Product Description 110

Table 202: Lonestar Heart Inc – Ongoing Clinical Trials Overview 111

Table 203: Algisyl-LVR Surgical Device – A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure 112

Table 204: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 113

Table 205: Device For Diastolic Heart Failure – Product Status 113

Table 206: Device For Diastolic Heart Failure – Product Description 113

Table 207: Implantable Left Ventricular Assist Device – Product Status 114

Table 208: Implantable Left Ventricular Assist Device – Product Description 114

Table 209: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 115

Table 210: Fully Implantable Left Ventricular Assist Device – Product Status 115

Table 211: Fully Implantable Left Ventricular Assist Device – Product Description 115

Table 212: Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview 116

Table 213: BioVAD – Product Status 116

Table 214: BioVAD – Product Description 116

Table 215: pediatric MPulse – Product Status 117

Table 216: pediatric MPulse – Product Description 117

Table 217: MyoCardioCare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118

Table 218: MCC3000 Heart Pump – Product Status 118

Table 219: MCC3000 Heart Pump – Product Description 118

Table 220: MCC3000 Heart Pump – Pediatrics – Product Status 119

Table 221: MCC3000 Heart Pump – Pediatrics – Product Description 119

Table 222: Myotech, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 120

Table 223: Myotech Circulatory Support System – Product Status 120

Table 224: Myotech Circulatory Support System – Product Description 120

Table 225: NeoCardial Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 121

Table 226: eHeart Extra Ventricular Assist Device – Product Status 121

Table 227: eHeart Extra Ventricular Assist Device – Product Description 121

Table 228: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 122

Table 229: BR16010 – Product Status 122

Table 230: BR16010 – Product Description 122

Table 231: Implantable Ventricular Assist Device – Product Status 123

Table 232: Implantable Ventricular Assist Device – Product Description 123

Table 233: Novapump GmbH Pipeline Products & Ongoing Clinical Trials Overview 124

Table 234: PERKAT Biventricular Heart Pump – Product Status 124

Table 235: PERKAT Biventricular Heart Pump – Product Description 124

Table 236: PERKAT RV – Product Status 125

Table 237: PERKAT RV – Product Description 125

Table 238: NuPulseCV Pipeline Products & Ongoing Clinical Trials Overview 126

Table 239: NuPulseCV iVAS – Product Status 126

Table 240: NuPulseCV iVAS – Product Description 126

Table 241: PediPulse – Product Status 127

Table 242: PediPulse – Product Description 127

Table 243: NuPulseCV – Ongoing Clinical Trials Overview 128

Table 244: NuPulseCV iVAS – A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study 129

Table 245: OregonHeart Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 130

Table 246: Next Generation Total Artificial Heart – Product Status 130

Table 247: Next Generation Total Artificial Heart – Product Description 130

Table 248: Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 131

Table 249: Pediatric Heart-Assist Device – Product Status 131

Table 250: Pediatric Heart-Assist Device – Product Description 131

Table 251: Perfusion Solution Inc Pipeline Products & Ongoing Clinical Trials Overview 132

Table 252: Cavopulmonary Assist System – Product Status 132

Table 253: Cavopulmonary Assist System – Product Description 132

Table 254: Right Ventricular Assist Device – Long Term Care – Product Status 133

Table 255: Right Ventricular Assist Device – Long Term Care – Product Description 133

Table 256: Transapical LVAD – Product Status 133

Table 257: Transapical LVAD – Product Description 134

Table 258: PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview 135

Table 259: Implantable Left Ventricular Assist Device – Product Status 135

Table 260: Implantable Left Ventricular Assist Device – Product Description 135

Table 261: Procyrion Inc Pipeline Products & Ongoing Clinical Trials Overview 136

Table 262: Aortix Device – Product Status 136

Table 263: Aortix Device – Product Description 136

Table 264: Procyrion Inc – Ongoing Clinical Trials Overview 137

Table 265: Aortix Device – An Evaluation of the Safety and Performance of the Aortix System for Intra-aortic Mechanical Circulatory Support in Patients with Cardiorenal Syndrome 138

Table 266: Purdue University Pipeline Products & Ongoing Clinical Trials Overview 139

Table 267: Viscous Impeller Pump – Infants – Product Status 139

Table 268: Viscous Impeller Pump – Infants – Product Description 139

Table 269: Puzzle Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 140

Table 270: ModulHeart – Product Status 140

Table 271: ModulHeart – Product Description 140

Table 272: ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 141

Table 273: aVAD Liberty System – Product Status 141

Table 274: aVAD Liberty System – Product Description 141

Table 275: Pulse Less Total Artificial Heart – Product Status 142

Table 276: Pulse Less Total Artificial Heart – Product Description 142

Table 277: VAD Maintenance System – Product Status 142

Table 278: VAD Maintenance System – Product Description 143

Table 279: RT Cardiac Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 144

Table 280: Percutaneous Mechanical Circulatory Support System – Product Status 144

Table 281: Percutaneous Mechanical Circulatory Support System – Product Description 144

Table 282: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 145

Table 283: Temporary Percutaneous Ventricular Assist Device – Product Status 145

Table 284: Temporary Percutaneous Ventricular Assist Device – Product Description 146

Table 285: Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview 147

Table 286: Total Artificial Heart – Product Status 147

Table 287: Total Artificial Heart – Product Description 147

Table 288: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 148

Table 289: Paracorporeal Left Ventricle Assist Device – Product Status 148

Table 290: Paracorporeal Left Ventricle Assist Device – Product Description 148

Table 291: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 149

Table 292: UltraMag Adult Ventricular Assist System – Product Status 149

Table 293: UltraMag Adult Ventricular Assist System – Product Description 149

Table 294: UltraMag Pediatric Ventricular Assist System – Product Status 150

Table 295: UltraMag Pediatric Ventricular Assist System – Product Description 150

Table 296: Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 151

Table 297: C-Pulse – Wireless Version – Product Status 151

Table 298: C-Pulse – Wireless Version – Product Description 151

Table 299: Supira Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 152

Table 300: Next Generation Percutaneous Ventricular Assist Device – Product Status 152

Table 301: Next Generation Percutaneous Ventricular Assist Device – Product Description 152

Table 302: Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview 153

Table 303: 10cc Ventricular Assist Device – Product Status 153

Table 304: 10cc Ventricular Assist Device – Product Description 153

Table 305: 30cc Ventricular Assist Device – Product Status 154

Table 306: 30cc Ventricular Assist Device – Product Description 154

Table 307: 60cc Ventricular Assist Device – Product Status 154

Table 308: 60cc Ventricular Assist Device – Product Description 155

Table 309: SynCardia 50cc Temporary Total Artificial Heart – Destination Therapy – Product Status 155

Table 310: SynCardia 50cc Temporary Total Artificial Heart – Destination Therapy – Product Description 155

Table 311: SynCardia 70cc Temporary Total Artificial Heart – Destination Therapy – Product Status 156

Table 312: SynCardia 70cc Temporary Total Artificial Heart – Destination Therapy – Product Description 156

Table 313: Syncardia Systems LLC – Ongoing Clinical Trials Overview 157

Table 314: SynCardia 70cc Temporary Total Artificial Heart – Destination Therapy – SynCardia 70cc Temporary Total Artificial Heart (TAH-t) for Destination Therapy (DT) 158

Table 315: TEDA International Cardiovascular Hospital Pipeline Products & Ongoing Clinical Trials Overview 159

Table 316: Artificial Heart – Product Status 159

Table 317: Artificial Heart – Product Description 159

Table 318: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 160

Table 319: DuraHeart Destination Therapy Left Ventricular Assist System – Product Status 160

Table 320: DuraHeart Destination Therapy Left Ventricular Assist System – Product Description 161

Table 321: The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Pipeline Products & Ongoing Clinical Trials Overview 162

Table 322: ReligaHeart EXT – Product Status 162

Table 323: ReligaHeart EXT – Product Description 162

Table 324: Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 163

Table 325: DuraHeart II – Product Status 163

Table 326: DuraHeart II – Product Description 163

Table 327: Fully Implantable Ventricular Assist System – Product Status 164

Table 328: Fully Implantable Ventricular Assist System – Product Description 164

Table 329: HeartMate X – Product Status 164

Table 330: HeartMate X – Product Description 165

Table 331: Tokyo Medical and Dental University Pipeline Products & Ongoing Clinical Trials Overview 166

Table 332: TinyPump – Product Status 166

Table 333: TinyPump – Product Description 166

Table 334: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 167

Table 335: SVAD – Product Status 167

Table 336: SVAD – Product Description 167

Table 337: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 168

Table 338: Paediatric Heart Pump – Product Status 168

Table 339: Paediatric Heart Pump – Product Description 168

Table 340: University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 169

Table 341: Helical Flow Total Artificial Heart – Product Status 169

Table 342: Helical Flow Total Artificial Heart – Product Description 169

Table 343: University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 170

Table 344: VADStent – Product Status 170

Table 345: VADStent – Product Description 170

Table 346: Vadovations Inc Pipeline Products & Ongoing Clinical Trials Overview 171

Table 347: REVOLUTION – Product Status 171

Table 348: REVOLUTION – Product Description 171

Table 349: VASCOR Inc Pipeline Products & Ongoing Clinical Trials Overview 172

Table 350: Vascor LVAD – Product Status 172

Table 351: Vascor LVAD – Product Description 172

Table 352: Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 173

Table 353: Pediatric TORVAD – Product Status 173

Table 354: Pediatric TORVAD – Product Description 173

Table 355: TORVAD – Product Status 174

Table 356: TORVAD – Product Description 174

Table 357: W-Z BIOTECH, LLC Pipeline Products & Ongoing Clinical Trials Overview 175

Table 358: Double Lumen Cannula-Based Left Ventricular Assist Device – Product Status 175

Table 359: Double Lumen Cannula-Based Left Ventricular Assist Device – Product Description 175

Table 360: Yale University Pipeline Products & Ongoing Clinical Trials Overview 176

Table 361: BoLetz Pump – Product Status 176

Table 362: BoLetz Pump – Product Description 176

Table 363: CAP RVAD Pump – Product Status 177

Table 364: CAP RVAD Pump – Product Description 177

Table 365: Corisma – Product Status 177

Table 366: Corisma – Product Description 178

Table 367: Glossary 227

List of Figures

Figure 1: Mechanical Circulatory Support Devices – Pipeline Products by Stage of Development 16

Figure 2: Mechanical Circulatory Support Devices – Pipeline Products by Segment 17

Figure 3: Mechanical Circulatory Support Devices – Pipeline Products by Territory 18

Figure 4: Mechanical Circulatory Support Devices – Pipeline Products by Regulatory Path 19

Figure 5: Mechanical Circulatory Support Devices – Pipeline Products by Estimated Approval Date 20

Figure 6: Mechanical Circulatory Support Devices – Ongoing Clinical Trials 21

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports